GLABF (Gemina Laboratories) Beginning Cash Position: $-0.01 Mil (As of Oct. 2025)


What is Gemina Laboratories Beginning Cash Position?

Gemina Laboratories GLABF -27.59% Beginning Cash Position is $-0.01 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's Beginning Cash Position for the quarter that ended in Oct. 2025 was $-0.01 Mil.

Gemina Laboratories's quarterly Beginning Cash Position increased from Apr. 2025 ($0.00 Mil) to Jul. 2025 ($0.02 Mil) but then declined from Jul. 2025 ($0.02 Mil) to Oct. 2025 ($-0.01 Mil).

Gemina Laboratories's annual Beginning Cash Position declined from Jan. 2023 ($0.86 Mil) to Jan. 2024 ($0.06 Mil) and declined from Jan. 2024 ($0.06 Mil) to Jan. 2025 ($0.00 Mil).

Gemina Laboratories Beginning Cash Position Related Terms

Gemina Laboratories Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Beginning Cash Position Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Beginning Cash Position
0.00 0.70 0.86 0.06 0.00

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.04 0.00 0.02 -0.01

Gemina Laboratories Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $-0.01 Mil mean?
Gemina Laboratories (GLABF) has a Beginning Cash Position of $-0.01 Mil as of Oct. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Beginning Cash Position too high?
Gemina Laboratories' current Beginning Cash Position is $-0.01 Mil.
How does Gemina Laboratories' Beginning Cash Position compare to VRTX and REGN?
Gemina Laboratories' Beginning Cash Position of $-0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current Beginning Cash Position is $-0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Beginning Cash Position of $-0.01 Mil. The current Beginning Cash Position is $-0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Beginning Cash Position is $-0.01 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.